Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
122 Cards in this Set
- Front
- Back
Antimicrobial agents
|
A special group of chemotherapeutic agents used to treat diseases caused by microbes
|
|
Antibiosis
|
Means "against life"
|
|
Antibiotic
|
A chemical substance produced by microorganisms which has the capacity to inhibit the growth of bacteria and even destroy bacteria and other microbes.
|
|
Synthetic drug
|
a drug synthesized in the laboratory
|
|
Semisynthetic drugs
|
partly made by laboratory synthesis
|
|
1910
|
Paul Ehrlich used Salvarsan to treat Syphillis (year)
|
|
1935
|
Gerhard Domagk discovered prontosil, a red dye, inhibits growth of many gram-positive bacteria (year)
|
|
1936
|
Ernest Fourneau discovered that the sulfanilamide portion contained antimicrobial activity
|
|
Selective toxicity
|
Antimicrobial drug must harm the microbes without causing significant damage to the host
|
|
Toxic host damage
|
causes host damage
|
|
Therapeutic dosage level
|
successfully eliminates the pathogenic organism if the level is maintained
|
|
The Spectrum of Activity
|
The range of different microbes against which an antimicrobial agent acts
|
|
Broad spectrum
|
Agents effective against both gram positive and gram negative bacteria
|
|
Narrow spectrum
|
Agents effective against a small number of microbes
|
|
toxicity, allergy, disruption of normal flora
|
Three categories of side effects of antimicrobial agents
|
|
natural selection, chromosomal mutation, extrachromosomal resistance (R plasmids or R factors)
|
Microorganisms normally acquire antibiotic resistance by genetic changes (3 examples)
|
|
B-lactam ring
|
attaches to the enzymes that cross-link peptidoglycans and prevent cell wall synthesis. Contained within Penicillin and cephalosporin
|
|
Antimetabolites
|
substances that affect the utilization of metabolites and therefore prevent a cell from carrying out necessary metabolic reactions.
|
|
alteration of targets, alteration of membrane permeability, development of enzymes, alteration of an enzyme, alteration of a metabolic pathway.
|
5 mechanisms of microorganism resistance
|
|
Pathogen
|
a parasite capable of causing disease in a host
|
|
Host
|
any organism that harbors another organism
|
|
Mutualism
|
both members of the association living together benefit from the relationship
|
|
Parasitism
|
one organism, the parasite, benefits from the relationship, whereas the other organism, the host, is harmed by it.
|
|
Commensalism
|
two species live together in a relationship such that one benefits and the other one neither benefits nor is harmed
|
|
Symbiosis
|
mutualism, commensalism and parasitism.
|
|
Contamination, infection and disease
|
can be viewed as a sequence of conditions in which the severity of the effects microbes have on their hosts increases.
|
|
Contamination
|
Means that microorganisms are present
|
|
Infection
|
Refers to the multiplication of any parasitic organism within or on the host's body
|
|
Disease
|
A disturbance in the state of health wherein the body cannot carry out all its normal functions
|
|
Pathogenicity
|
The capacity to produce disease
|
|
Virulence
|
Refers to the intensity of the disease produced by pathogens, and it varies among different microbial species.
|
|
Animal Passage
|
The rapid transfer of the pathogen through animals of a species susceptible to infection by that pathogen
|
|
Attenuation
|
The weakening of the disease-producing ability of the pathogen.
|
|
Normal (indigenous) Microflora
|
organisms that live on or in the body but do not cause disease and have well-established associations with humans.
|
|
Resident Microflora
|
comprise microbes that are always present on or in the human body
|
|
Transient Microflora
|
microbes that can be present under certain conditions in any of the locations where resident microflora are found.
|
|
Infectious Diseases
|
caused by infectious agents such as bacteria, viruses, fungi, protozoa, helminths.
|
|
Non-Infectious Diseases
|
Caused by any other factor other than infectious organisms
|
|
Inherited diseases
|
Diseases that are caused by errors in genetic information
|
|
Congenital Diseases
|
Diseases that are structural and functional defects present at birth
|
|
Degenerative Diseases
|
Disorders that develop in one or more body system as aging occurrs
|
|
Nutrional Deficiency Diseases
|
diseases that lower resistance to infectious diseases and contribute to the severity of infections
|
|
Mental Diseases
|
can be caused by a variety of factors (emotional, psychogenic or infection)
|
|
Immunological Diseases
|
diseases such as allergies, autoimmune diseases, and immunodeficiencies
|
|
Neoplastic Diseases
|
involve abnormal cell growth that leads to harmless or cancerous tumors
|
|
Iatrogenic Diseases
|
diseases that are caused by medical procedures and/or treatments
|
|
Idiopathic Diseases
|
Diseases whos causes are unknown
|
|
Toxin
|
any substance that is poisonous to other organisms
|
|
Exotoxins
|
Soluble substances secreted into host tissues, some are enzymes
|
|
Endotoxins
|
part of the cell wall and are released into host tissues from gram negative bacteria
|
|
Cytopathic Effect (CPE)
|
in tissue culture systems, once inside a cell, viruses cause these observable changes
|
|
Productive Viral Infection
|
Occurs when viruses enter a cell and produce infectious offspring
|
|
Abortive Viral Infection
|
occurs when viruses enter a cell but are unable to express all their genes to make infectious offspring
|
|
Latent Viral Infection
|
a weakened immune system allows the virus to multiply
|
|
Persistent Viral Infections
|
involve a continued production of viruses over many months or years. May be so chronic that there are no outward signs of an infection.
|
|
Mycotoxins
|
Produced by certain fungi. Cause disease if ingested by humans
|
|
Helminths
|
Extracellular parasites that inhabit intestines or other body tissues and many release toxic waste products and antigens in their excretions
|
|
Sign
|
a characteristic of a disease that can be observed by examining the patient
|
|
Symptom
|
a characteristic of a disease that can be observed or felt only by the patient
|
|
Syndrome
|
a combination of signs and symptoms that occur together and are indicative of a particular disease or abnormal combination
|
|
Sequelae
|
even after recovery, some diseases have after-effects
|
|
Incubation Period
|
the time between infection and appearance of signs and symptoms
|
|
Prodromal Phase
|
a short period during which nonspecific, often mild symptoms appear
|
|
Prodrome
|
a symptom indicating the onset of a disease
|
|
Invasive Phase
|
a period during which the individual experiences the typical signs and symptoms of the disease
|
|
Decline Phase
|
the period of illness during which host defenses and effects of treatment overcome the pathogen
|
|
Covalescent Period
|
Tissues are repaired, healing takes place, and body regains strength and recovers.
|
|
Innate Defenses
|
those that act against any type of invading agent
|
|
Adaptive Defenses
|
respond to particular agents called antigens (e.g. viruses and pathogenic bacteria) by producing protein antibodies and activate lymphocytes
|
|
Physical Barriers
|
skin and mucous membranes and chemicals they secrete
|
|
Chemical Barriers
|
antimicrobial substances in body fluids (saliva, mucus, gastic juices, iron limitation mech)
|
|
Cellular Defenses
|
certain cells that engulf invading microorganisms
|
|
Inflammation
|
reddening, swelling and temperature to kill invading agents/inactivate their toxic products
|
|
Molecular defenses
|
interferon and complement that destroy or impede invading microorganisms.
|
|
Complement
|
Most effective non-specific molecular defense mechanism
|
|
Chemotaxis
|
Process that includes PRR's, cytokines and chemokines.
|
|
Pattern Recognition Receptors (PRR's)
|
recognize molecular patterns unique to pathogen on the phagocytic cells
|
|
Chemokines
|
a class of cytokines that attract additional phagocytes to the site of infection
|
|
Adherence
|
the ability of the phagocyte cell membrane to bind to specific molecules on the surface of the microbe
|
|
Antiphagocytic capsule
|
the most common means by which bacteria avoid phagocytosis
|
|
Complement System
|
coat microbes with antibodies to aid in phagocyte adherence
|
|
Phagosome
|
pseudopodia fuse and enclose microorganism within this cytoplasmic vacuole
|
|
Phagolysosome
|
lysosomes with digestive enzymes fuse with phagosome embrane
|
|
Inflammation
|
the body's defensive response to tissue damage from microbial infection
|
|
Calor
|
An increase in temperature (heat)
|
|
Rubor
|
redness
|
|
Tumor
|
Swelling
|
|
Dolor
|
Pain at infected or injured site
|
|
Cascade
|
a set of reactions that amplify some effect
|
|
Molecular Defenses
|
These defenses involve the action of interferon and complement
|
|
Interferon
|
Interfere with viral replication in other cells
|
|
Human Beta Defensin II
|
destroys pathogens by poking holes in bacterial membranes (on skin)
|
|
Immunity
|
refers to the ability of the organism to recognize and defend itself against infectious agents
|
|
Susceptibility
|
opposite of immunity, the vulnerability of the host to be harmed by infectious agents.
|
|
Immunology
|
the study of adaptive immunity and how the immune system responds to specific infectious agents and toxins
|
|
Immune System
|
consists of various cells, especially lymphocyte, and organs such as the thymus gland that help provide the host with specific immunity to infectious agents.
|
|
Naturally Acquired Adaptive Immunity
|
most often obtained by having a specific disease
|
|
Artificially Aquired Adaptive Immunity
|
obtained by receiving an antigen by injection of a vaccine or immune system (passive)
|
|
Antigen
|
a substance the body identifes as foreign and toward which it mounts an immune response.
|
|
Hapten
|
a small molecule can act as an antigen if it binds to a larger protein molecule
|
|
Antibody
|
a protein produced in response to an antigen that is capable of binding specifically to the antigen.
|
|
Titer
|
the quantity of a substance needed to produce a given reaction.
|
|
B lymphocytes (B cells)
|
lymphocytes are processed and mature in tissue, referred to as bursal-equivalent tissue.
|
|
T lymphocytes (T cells)
|
stem cells migrate to the thymus, where they undergo differentiation into thymus-derived cells
|
|
Natural Killer Cells
|
found in tissues circulating in blood and nonspecifically kill cancer cells and viral-infected cells
|
|
Humoral immunity (B cells) and cell-mediated immunity (cytotoxic T cells)
|
Lymphocytes give rise to these two major types of immune responses
|
|
Constant regions of antibodies
|
determines the particular class than an immunoglobulin belongs to
|
|
Variable region of an antibody
|
each chain has a particular shape and charge that enable the molecule to bind to a particular antigen
|
|
IgG
|
the main class of antibodies that is found in the blood and accounts for as much as 20% of all plasma proteins
|
|
IgA
|
class of antibodies that occur in small amounts in blood and larger amounts in body secretions
|
|
IgM
|
class of antibodies that are found as a monomer on the surface of B cells and is secreted as a pentamer by plasma cells
|
|
IgE
|
class of antibodies that have a special affinity for receptors on the plasma membranes of basophils in blood or mast cell tissues. Present in patients with allergies.
|
|
IgD
|
class of antibodies that are found mainly on B cell membranes
|
|
Active Immunization
|
the process of inducing active immunity. Can be conferred by administering vaccines or toxoids.
|
|
Vaccine
|
a substance that contains an antigen to which the immune system responds
|
|
Toxoid
|
an inactivated toxin that is no longer harmful but retains its antigenic properties.
|
|
Antisera
|
antibodies that are found in the serum and are introduced into an unprotected individual.
|
|
Immunological Disorder
|
a condition that results from an inappropriate or inadequate immune response
|
|
Hypersensitivity
|
the immune system reacts in an exaggerated or inappropriate way to a foreign substance.
|
|
Transfusion Reaction
|
when matching antigens and antibodies are present in the patients blood at the same time.
|
|
Sensitization
|
when an Rh-negative woman carries an Rh positive fetus and produces anti-Rh antibodies if it again encounters with the Rh antigen
|
|
Granulomatous Hypersensitivity
|
most serious and usually occurs when macrophages have engulfed pathogens but have failed to kill them.
|